US2006115864A1PendingUtilityA1
Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
Est. expiryApr 3, 2020(expired)· nominal 20-yr term from priority
G01N 33/542Y10T436/255G01N 33/6842G01N 2500/02G01N 2500/00G01N 2333/9015C12Q 1/25G01N 33/68Y10S436/805G01N 33/5008C12Q 1/37G01N 2500/04G01N 33/573
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methods and compositions for assaying for ubiquitin agents that are enzymatic components of ubiquitin-mediated proteolysis and, more particularly, methods and compositions for assaying for agents that modulate the activity of such ubiquitin agents.
Claims
exact text as granted — not AI-modified1 . A method of assaying for an agent that modulates the attachment of a ubiquitin moiety to at least one ubiquitin agent, said method comprising:
a) combining:
i) a first ubiquitin agent;
ii) a candidate agent; and
iii) a ubiquitin moiety; and
b) assaying for the attachment of said ubiquitin moiety to said first agent.
2 . The method according to claim 1 , wherein said first ubiquitin agent is an ubiquitin activating agent.
3 . The method according to claim 2 , wherein said ubiquitin activating agent is an E1.
4 . The method according to claim 1 , further comprising including a second ubiquitin agent in said combining step.
5 . The method according to claim 4 , wherein said first agent is a ubiquitin conjugating agent and said second agent is a ubiquitin activating agent.
6 . The method according to claim 5 , wherein said ubiquitin conjugating agent is an E2 and said ubiquitin activating agent is an E1.
7 . The method according to claim 4 , wherein said first agent is a ubiquitin ligating agent and said second agent is a ubiquitin conjugating agent comprising said ubiquitin moiety.
8 . The method according to claim 7 , wherein said ubiquitin ligating agent is an E3 and said ubiquitin conjugating agent is an E2 comprising said ubiquitin moiety.
9 . The method according to claim 5 , wherein said ubiquitin conjugating agent is an E2 and said ubiquitin activating agent is an E1 comprising said ubiquitin moiety.
10 . The method according to claim 9 further comprising including a third ubiquitin agent in said combining step.
11 . The method according to claim 10 , wherein said third agent is a ubiquitin ligating agent.
12 . The method according to claim 11 , wherein said ubiquitin ligating agent is an E3.
13 . The method according to claim 1 , wherein said first ubiquitin agent is attached to a solid support.
14 . The method according to claims 4 , wherein said second ubiquitin agent is attached to a solid support.
15 . The method according to claim 7 , wherein said first ubiquitin agent is attached to a solid support.
16 . The method according to any of claims 13 , 14 , and 15 , wherein said solid support is a microtiter plate.
17 . The method according to any of claims 13 , 14 , and 15 , wherein said solid support is a bead.
18 . The method according to claims 1 or 7 , wherein said first agent comprises a tag.
19 . The method according to claim 4 , wherein said second agent comprises a tag.
20 . The method according to any of claims 1 , 4 , and 7 , wherein said ubiquitin moiety comprises a tag.
21 . The method according to claims 1 or 7 , wherein said first agent comprises an attachment tag.
22 . The method according to claim 4 , wherein said second agent comprises an attachment tag.
23 . The method according to claims 1 or 7 , wherein said first agent comprises a label
24 . The method according to claim 4 , wherein said second agent comprises a label.
25 . The method according to claims 1 or 7 , wherein said first agent comprises an epitope tag.
26 . The method according to claim 4 , wherein said second agent comprises an epitope tag.
27 . The method according to any of claims 1 , 4 , and 7 , wherein at least a first and a second ubiquitin moiety is used, wherein said first and second ubiquitin moiety moieties comprise different fluorescent labels, and wherein said labels form a fluorescence resonance energy transfer (FRET) pair.
28 . A method of assaying for an agent that modulates the attachment of a ubiquitin moiety to at least one ubiquitin agent, said method comprising:
a) combining:
i) a first ubiquitin agent comprising a ubiquitin ligating agent;
ii) a second ubiquitin agent;
iii) a candidate agent;
iv) a ubiquitin moiety; and
v) a target protein; and
assaying for the attachment of said ubiquitin moiety to said first agent.
29 . The method according to claim 28 , wherein said second agent is a ubiquitin conjugating agent comprising said ubiquitin moiety.
30 . The method according to claim 28 further comprising including a third ubiquitin agent in said combining step, wherein said third agent is a ubiquitin activating agent; wherein said substrate and said ubiquitin moiety comprise different fluorescent labels, and wherein said labels form a fluorescence resonance energy transfer (FRET) pair.
31 . The method according to claim 1 or 28 , wherein said ubiquitin moiety is a mammalian ubiquitin moiety.
32 . The method according to claim 28 , wherein said ubiquitin moiety comprises a label.
33 . The method according to claim 28 , wherein said label comprises an epitope tag.Join the waitlist — get patent alerts
Track US2006115864A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.